 SOUTH SAN FRANCISCO, Calif., Oct. 28, 2020 PRNewswire -- Titan Pharmaceuticals, Inc. NASDAQ: TTNP today announced the pricing of an underwritten public offering of 80,000,000 units at a price of 0.10 per unit. Each unit issued in the offering consists of one share of common stock and... 